The Fasting Mimicking Diet with Prolon’s Dr. James Kelley

Today I sit down with James Kelley, MD, MBA, Consulting Medical Science Liaison of Pronlon. I am on my 2nd round of it in two months and it is quite the experience.  Click here for my link where you can get 10% off (that’s $25 a box plus free shipping) - use GROOMEDLA or GROOMEDLASUB (for a subscription). Excited to hear your thoughts!  “The main health benefits of the Fasting Mimicking Diet are due to the metabolic and cellular effects of the diet. While most diets focus on weight loss, the Fasting Mimicking Diet not only induces weight loss but also maintains healthy levels of cholesterol, triglycerides, blood sugar and other important health markers. Due to these effects, the Fasting Mimicking Diet was granted the first patent in history on promoting tissue/organ regeneration, Longevity and Healthspan July 10th, 2018. The FMD holds multiple patents discovered and clinically tested by the laboratory of Valter Longo and Keck Hospital at the University of Southern California (USC). These patents are exclusively licensed to L-Nutra and include indications such as cancer, auto-immune diseases, diabetes, and cardiovascular diseases. USC and multiple research centers around the world are currently researching the impact of the FMD on these diseases.” James brings both clinical and business experience to L-Nutra. His background is in the development of early stage medical and biotechnology, in addition to working with physicians, nurses and other healthcare professionals. James completed his M.D. at The Ohio State University, and was the inaugural Research Fellow at the Ohio Health Research and Innovation Institute. He finished his MBA at the University of Southern California Marshall School of Business. He has worked with the USC Alfred Mann Institute for Biomedical Engineering, the Lloyd Grief Center for Entrepreneurial Studies, and the Stevens Institute of Technology. He holds a Bachelor’s degree in Cell Biology from the University of Virginia, and completed his Neuroscience Masters coursework at Miami University. Prior to joining the L-Nutra team, he was the head of Inventor Services at The Innovation Institute, a partnership with the Cleveland Clinic Innovations group focused on developing and commercializing new and innovative healthcare solutions. ProLon launched in the United States on September 21, 2016, and quickly expanded into 12 international countries. Today, ProLon has globally impacted the lives of 80,000 consumers in the United States and Europe. L-Nutra will be expanding into Canada, Mexico, Australia, New Zealand, Middle East, Japan and China. The company is on track to be one of the fastest growing nutri-technology companies with breakthrough scientific research and a rich pipeline of fasting mimicking diets. ProLon has helped over 80,000 individuals to improve their wellbeing. More than 5,500 healthcare providers have recommended ProLon to their patients. “Our goal is to scientifically uncover all the health benefits of fasting and make them available to billions of individuals,” says Dr. Antoun. “We are aiming at enhancing human longevity by many years, and we believe it is within in our reach,” continued Dr. Antoun.<